Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest versus medroxyprogesterone acetate before hysteroscopy for submucosal myoma
IRCT20120201008897N11Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Fibromyoma (LM) comparing Medroxyprogesterone acetate with Dienogest (2 arms). Primary endpoint: Volume deficit. Started Apr 2025; status: completed.
02
Drugs
dienogestmedroxyprogesterone acetate
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT20120201008897N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120201008897N11.